Skip to main content

Table 2 Odds ratios of low or high plasma potassium associated with baseline patient characteristics – Multinomial logistic regression using patients with plasma potassium of 4–5 mmol/L as the reference group

From: Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study

  

Plasma potassium (mmol/L)

<4

>5

Age (per year)

 

0.99 (0.98–1.00)

0.98 (0.96–0.99)

Women vs men

 

1.49 (1.16–1.90)

0.47 (0.30–0.72)

Sub-Saharan vs other ethnicity

1.35 (0.99–1.83)

1.15 (0.66–1.99)

mGFR (ml/min/1.73m2)

 

<15

0.11 (0.05–0.23)

29.65 (10.87–80.88)

 

15–30

0.26 (0.18–0.38)

13.58 (5.71–32.3)

 

30–45

0.47 (0.34–0.63)

5.70 (2.42–13.45)

 

45–60

0.67 (0.49–0.90)

2.70 (1.07–6.85)

 

>60

1

1

BMI

 

<19

1.46 (0.83–2.59)

1.49 (0.65–3.43)

 

19–25

1

1

 

25–30

0.85 (0.66–1.10)

0.78 (0.51–1.20)

 

>30

0.78 (0.57–1.07)

1.05 (0.65–1.73)

Smoking status

 

Never smoked

1

1

 

Former smoker

0.85 (0.66–1.11)

1.02 (0.67–1.54)

 

Active smoker

0.76 (0.54–1.06)

1.66 (1.03–2.67)

Mean blood pressure (per mmHg)

1.01 (1.00–1.02)

1.01 (0.99–1.02)

Cardio-vascular history

0.63 (0.46–0.88)

0.81 (0.51–1.28)

ACR (mg/mmol)

 

<3

1

1

 

3–30

1.07 (0.82–1.40)

1.25 (0.76–2.08)

 

>30

0.80 (0.59–1.10)

1.13 (0.67–1.90)

Diabetes

 

0.86 (0.66–1.13)

1.56 (1.04–2.34)

Urine potassium

0.99 (0.99–1.00)

1.01 (1.00–1.01)

Serum albumin

 

≥35

1

1

 

<35

1.23 (0.87–1.74)

1.23 (0.76–1.98)

Serum potassium increasing drugsa

 

0.58 (0.44–0.78)

2.50 (1.17–5.35)

Serum potassium-lowering drugsb

1.70 (1.33–2.17)

1.01 (0.69–1.49)

  1. a ACEi or ARBs or potassium-sparing diuretics b loop or thiazide diuretic, kayexalate or bicarbonates
  2. BMI, body mass index, CVD, cardiovascular disease, mGFR, measured GFR, ACR, ratio of urinary albumin to creatinine
  3. The analyses was adjusted for center